United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Mereo BioPharma completes patient enrollment for BPS-804 Phase 2b trial in osteogenesis imperfecta British specialty biopharma company Mereo BioPharma Group has completed patient enrollment for a Phase 2b clinical trial of… bypharmanewsdailyOctober 30, 2018
